Correlation Between Erasca and ESSA Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Erasca and ESSA Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erasca and ESSA Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erasca Inc and ESSA Pharma, you can compare the effects of market volatilities on Erasca and ESSA Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erasca with a short position of ESSA Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erasca and ESSA Pharma.

Diversification Opportunities for Erasca and ESSA Pharma

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Erasca and ESSA is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and ESSA Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESSA Pharma and Erasca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erasca Inc are associated (or correlated) with ESSA Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESSA Pharma has no effect on the direction of Erasca i.e., Erasca and ESSA Pharma go up and down completely randomly.

Pair Corralation between Erasca and ESSA Pharma

Given the investment horizon of 90 days Erasca Inc is expected to under-perform the ESSA Pharma. In addition to that, Erasca is 2.16 times more volatile than ESSA Pharma. It trades about -0.18 of its total potential returns per unit of risk. ESSA Pharma is currently generating about -0.02 per unit of volatility. If you would invest  161.00  in ESSA Pharma on December 24, 2024 and sell it today you would lose (5.00) from holding ESSA Pharma or give up 3.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Erasca Inc  vs.  ESSA Pharma

 Performance 
       Timeline  
Erasca Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Erasca Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
ESSA Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ESSA Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, ESSA Pharma is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Erasca and ESSA Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Erasca and ESSA Pharma

The main advantage of trading using opposite Erasca and ESSA Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erasca position performs unexpectedly, ESSA Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will offset losses from the drop in ESSA Pharma's long position.
The idea behind Erasca Inc and ESSA Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Share Portfolio
Track or share privately all of your investments from the convenience of any device